tweenvest

Windward Bio Group AG (NasdaqGS: WWB)

Health Care · Biotechnology · CH

$24.01

+6.05% today · -15.8% 1Y

Public summary
A free snapshot of Windward Bio Group AG, with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Windward Bio Group AG (NasdaqGS: WWB) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.39B and employs 33 people.

Over the last twelve months the share price has lost 15.8%, trading between 22.64 and 30.04.

Tweenvest scores Windward Bio Group AG across four factors: quality 58/100, value 100/100. Its strongest factor is value.

WWB price history

Nov 13, 2026 · 28.50Weekly closes 24.01 – 28.50Nov 19, 2026 · 24.01

Key figures

Market cap
$1.39B
Revenue (TTM)
—
P/E
-20.43
EPS
-8.69
Dividend yield
—
Beta (5Y)
—
52-week high
$30.04
52-week low
$22.64
Avg volume (3M)
—
Shares outstanding
58.04M
Employees
33
Next earnings
—

About Windward Bio Group AG

Operates as a holding company whose subsidiaries develops and commercializes therapeutics

Founded
2024
Listed since
Nov 13, 2026
Exchange
Nasdaq Global Select
Currency
USD
CompanyMarket capPriceDay
Oncolys BioPharma Inc.TSE: 4588$1.41B¥7,620.00-5.69%
Intellia Therapeutics, Inc.NasdaqGM: NTLA$1.41B$10.05+5.51%
OliX Pharmaceuticals, IncKOSDAQ: A226950$1.41B₩82,400.00+4.97%
D&D Pharmatech Inc.KOSDAQ: A347850$1.40B₩40,700.00-2.51%
AnaptysBio, Inc.NasdaqGS: ANAB$1.39B$46.63-1.62%
Tyra Biosciences, Inc.NasdaqGS: TYRA$1.38B$20.03+1.32%
Immunocore Holdings plcNasdaqGS: IMCR$1.38B$26.63-3.20%
Wuhan Healthgen Biotechnology Corp.SHSE: 688765$1.37BCN¥25.67-5.87%

Browse every Biotechnology company →